Raras
Buscar doenças, sintomas, genes...
Doença de organelas lisossoma-relacionado
ORPHA:309340DOENÇA RARA

Antígeno de histocompatibilidade HLA classe II, cadeia alfa do DM, é uma proteína que em humanos é codificada pelo gene HLA-DMA.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença rara caracterizada por disfunção de organelas lisossomais, manifestando-se com endometriose, contraturas articulares, problemas ungueais e cutâneos, perda óssea e anomalias hematológicas. Associada a mutações em genes como AP3B1 e BLOC1S3.

Medicamentos
4 registrados
SORAFENIB, BOSENTAN, LETROZOLE

Tem tratamento?

4 medicamentos registrados
Ver detalhes, fases e interações →
SORAFENIBBOSENTANLETROZOLEPENTOXIFYLLINE
🏥
SUS: Cobertura mínimaScore: 20%
Centros em: PA, PR, SC, RS, ES +8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
26 sintomas
🧬
Pele e cabelo
25 sintomas
👁️
Olhos
24 sintomas
🩸
Sangue
18 sintomas
🫃
Digestivo
13 sintomas
🦴
Ossos e articulações
10 sintomas

+ 94 sintomas em outras categorias

Características mais comuns

Endometriose
Contratura em flexão do pododáctilo
Depressões ungueais
Pele seca
Acroosteólise das falanges distais (pés)
Contratura em flexão do dedo
253sintomas
Sem dados (253)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 253 características clínicas mais associadas, ordenadas por frequência.

EndometrioseEndometriosis
Contratura em flexão do pododáctiloFlexion contracture of toe
Depressões ungueaisNail pits
Pele secaDry skin
Acroosteólise das falanges distais (pés)Acroosteolysis of distal phalanges (feet)

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa10
Últimos 10 anos31publicações
Pico20205 papers
Linha do tempo
20202016Hoje · 2026📈 2020Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

14 genes identificados com associação a esta condição.

BLOC1S3Biogenesis of lysosome-related organelles complex 1 subunit 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Plays a role in intracellular vesic

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 8

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 8Hermansky-Pudlak syndrome 7
HGNC:20914UniProt:Q6QNY0
RBSNRabenosyn-5Candidate gene tested inTolerante
FUNÇÃO

Rab4/Rab5 effector protein acting in early endocytic membrane fusion and membrane trafficking of recycling endosomes. Required for endosome fusion either homotypically or with clathrin coated vesicles. Plays a role in the lysosomal trafficking of CTSD/cathepsin D from the Golgi to lysosomes. Also promotes the recycling of transferrin directly from early endosomes to the plasma membrane. Binds phospholipid vesicles containing phosphatidylinositol 3-phosphate (PtdInsP3) (PubMed:11062261, PubMed:11

LOCALIZAÇÃO

Cell membraneEarly endosome membrane

VIAS BIOLÓGICAS (2)
Toll Like Receptor 9 (TLR9) CascadeFactors involved in megakaryocyte development and platelet production
MECANISMO DE DOENÇA

Kariminejad neurodevelopmental syndrome

An autosomal recessive disorder characterized by global developmental delay, progressive muscle weakness, facial dysmorphisms, ophthalmoplegia and intellectual disability.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
29.0 TPM
Cerebelo
23.7 TPM
Artéria tibial
21.7 TPM
Ovário
21.4 TPM
Tireoide
21.1 TPM
OUTRAS DOENÇAS (4)
Kariminejad neurodevelopmental syndromemyelofibrosis, congenital, with anemia, neutropenia, developmental delay, and ocular abnormalitiesprogressive hypotonia-intellectual disability-facial dysmorphism syndrome due to FYVE-defective RBSNsevere congenital myelofibrosis-pancytopenia-intellectual disability-neurologic and ophthalmic abnormalities syndrome
HGNC:20759UniProt:Q9H1K0
AP3B1AP-3 complex subunit beta-1Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Subunit of non-clathrin- and clathrin-associated adaptor protein complex 3 (AP-3) that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules. AP-3 appears to be involved in the sorting of a subset of transmembrane proteins targeted to lysosomes and lysosome-related organelles. In concert w

LOCALIZAÇÃO

Cytoplasmic vesicle, clathrin-coated vesicle membraneGolgi apparatus

VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 2

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. HPS2 differs from the other forms of HPS in that it includes immunodeficiency in its phenotype and patients with HPS2 have an increased susceptibility to infections.

OUTRAS DOENÇAS (1)
Hermansky-Pudlak syndrome 2
HGNC:566UniProt:O00203
BLOC1S5Biogenesis of lysosome-related organelles complex 1 subunit 5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes (PubMed:32565547). In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Plays a role in i

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 11

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 11Hermansky-Pudlak syndrome 7
HGNC:18561UniProt:Q8TDH9
AP3D1AP-3 complex subunit delta-1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Part of the AP-3 complex, an adaptor-related complex which is not clathrin-associated. The complex is associated with the Golgi region as well as more peripheral structures. It facilitates the budding of vesicles from the Golgi membrane and may be directly involved in trafficking to lysosomes. Involved in process of CD8+ T-cell and NK cell degranulation (PubMed:26744459). In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery int

LOCALIZAÇÃO

CytoplasmGolgi apparatus membrane

MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 10

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS. HPS10 patients manifest albinism, neutropenia, immunodeficiency, neurodevelopmental delay, generalized seizures, and impaired hearing.

OUTRAS DOENÇAS (3)
Hermansky-Pudlak syndrome 10ocular albinism with late-onset sensorineural deafnessX-linked recessive ocular albinism
HGNC:568UniProt:O14617
HPS6BLOC-2 complex member HPS6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May regulate the synthesis and function of lysosomes and of highly specialized organelles, such as melanosomes and platelet dense granules (PubMed:17041891). Acts as a cargo adapter for the dynein-dynactin motor complex to mediate the transport of lysosomes from the cell periphery to the perinuclear region. Facilitates retrograde lysosomal trafficking by linking the motor complex to lysosomes, and perinuclear positioning of lysosomes is crucial for the delivery of endocytic cargos to lysosomes,

LOCALIZAÇÃO

Microsome membraneCytoplasm, cytosolEarly endosome membraneLysosome membrane

MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 6

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
30.4 TPM
Linfócitos
26.4 TPM
Fallopian Tube
19.4 TPM
Útero
18.1 TPM
Baço
17.0 TPM
OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 6Hermansky-Pudlak syndrome without pulmonary fibrosis
HGNC:18817UniProt:Q86YV9
HPS5BLOC-2 complex member HPS5Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May regulate the synthesis and function of lysosomes and of highly specialized organelles, such as melanosomes and platelet dense granules. Regulates intracellular vesicular trafficking in fibroblasts. May be involved in the regulation of general functions of integrins

LOCALIZAÇÃO

Cytoplasm, cytosol

MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 5

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
30.6 TPM
Testículo
25.4 TPM
Linfócitos
25.0 TPM
Fibroblastos
23.6 TPM
Aorta
20.7 TPM
OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 5Hermansky-Pudlak syndrome without pulmonary fibrosis
HGNC:17022UniProt:Q9UPZ3
HPS1BLOC-3 complex member HPS1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the BLOC-3 complex, a complex that acts as a guanine exchange factor (GEF) for RAB32 and RAB38, promotes the exchange of GDP to GTP, converting them from an inactive GDP-bound form into an active GTP-bound form. The BLOC-3 complex plays an important role in the control of melanin production and melanosome biogenesis and promotes the membrane localization of RAB32 and RAB38 (PubMed:23084991)

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
RAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 1

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
57.7 TPM
Cervix Endocervix
54.4 TPM
Cervix Ectocervix
48.5 TPM
Sangue
48.2 TPM
Útero
47.2 TPM
OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 1Hermansky-Pudlak syndrome with pulmonary fibrosis
HGNC:5163UniProt:Q92902
LYSTLysosomal-trafficking regulatorDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Adapter protein that regulates and/or fission of intracellular vesicles such as lysosomes (PubMed:11984006, PubMed:25216107). Might regulate trafficking of effectors involved in exocytosis (PubMed:25425525). In cytotoxic T-cells and natural killer (NK) cells, has role in the regulation of size, number and exocytosis of lytic granules (PubMed:26478006). In macrophages and dendritic cells, regulates phagosome maturation by controlling the conversion of early phagosomal compartments into late phago

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (3)
RUNX2 regulates osteoblast differentiationFormation of the anterior neural plateFormation of the posterior neural plate
MECANISMO DE DOENÇA

Chediak-Higashi syndrome

A rare autosomal recessive disorder characterized by hypopigmentation, severe immunologic deficiency, a bleeding tendency, neurologic abnormalities, abnormal intracellular transport to and from the lysosome, and giant inclusion bodies in a variety of cell types. Most patients die at an early age unless they receive an allogeneic hematopoietic stem cell transplant (SCT).

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
14.6 TPM
Cerebelo
14.6 TPM
Nervo tibial
12.8 TPM
Tecido adiposo
12.7 TPM
Skin Not Sun Exposed Suprapubic
12.2 TPM
OUTRAS DOENÇAS (2)
Chediak-Higashi syndromeattenuated Chédiak-Higashi syndrome
HGNC:1968UniProt:Q99698
BLOC1S6Biogenesis of lysosome-related organelles complex 1 subunit 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. May play a role in intracellular ve

LOCALIZAÇÃO

CytoplasmMembrane

VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 9

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 9Hermansky-Pudlak syndrome 7
HGNC:8549UniProt:Q9UL45
CTSCDipeptidyl peptidase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Thiol protease (PubMed:1586157). Has dipeptidylpeptidase activity (PubMed:1586157). Active against a broad range of dipeptide substrates composed of both polar and hydrophobic amino acids (PubMed:1586157). Proline cannot occupy the P1 position and arginine cannot occupy the P2 position of the substrate (PubMed:1586157). Can act as both an exopeptidase and endopeptidase (PubMed:1586157). Activates serine proteases such as elastase, cathepsin G and granzymes A and B (PubMed:8428921)

LOCALIZAÇÃO

Lysosome

VIAS BIOLÓGICAS (1)
MHC class II antigen presentation
MECANISMO DE DOENÇA

Papillon-Lefevre syndrome

An autosomal recessive disorder characterized by palmoplantar keratosis and severe periodontitis affecting deciduous and permanent dentitions and resulting in premature tooth loss. The palmoplantar keratotic phenotype vary from mild psoriasiform scaly skin to overt hyperkeratosis. Keratosis also affects other sites such as elbows and knees.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
104.9 TPM
Pulmão
61.5 TPM
Baço
57.1 TPM
Linfócitos
52.9 TPM
Adipose Visceral Omentum
38.4 TPM
OUTRAS DOENÇAS (3)
periodontitis, aggressive 1Haim-Munk syndromePapillon-Lefevre disease
HGNC:2528UniProt:P53634
HPS3BLOC-2 complex member HPS3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in early stages of melanosome biogenesis and maturation

LOCALIZAÇÃO

CytoplasmCytoplasm, cytosol

MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 3

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
27.4 TPM
Linfócitos
24.4 TPM
Útero
22.8 TPM
Nervo tibial
21.4 TPM
Baço
18.9 TPM
OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 3Hermansky-Pudlak syndrome without pulmonary fibrosis
HGNC:15597UniProt:Q969F9
HPS4BLOC-3 complex member HPS4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the BLOC-3 complex, a complex that acts as a guanine exchange factor (GEF) for RAB32 and RAB38, promotes the exchange of GDP to GTP, converting them from an inactive GDP-bound form into an active GTP-bound form. The BLOC-3 complex plays an important role in the control of melanin production and melanosome biogenesis and promotes the membrane localization of RAB32 and RAB38 (PubMed:23084991)

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
RAB GEFs exchange GTP for GDP on RABs
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 4

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
67.3 TPM
Cérebro - Hemisfério cerebelar
66.6 TPM
Testículo
44.7 TPM
Skin Sun Exposed Lower leg
40.8 TPM
Skin Not Sun Exposed Suprapubic
36.3 TPM
OUTRAS DOENÇAS (2)
Hermansky-Pudlak syndrome 4Hermansky-Pudlak syndrome with pulmonary fibrosis
HGNC:15844UniProt:Q9NQG7
DTNBP1DysbindinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Associates with the BLOC-2 complex

LOCALIZAÇÃO

CytoplasmCytoplasmic vesicle membraneEndosome membraneMelanosome membranePostsynaptic densityEndoplasmic reticulumNucleusCytoplasmic vesicle, secretory vesicle, synaptic vesicle membranePostsynaptic cell membrane

VIAS BIOLÓGICAS (1)
Golgi Associated Vesicle Biogenesis
MECANISMO DE DOENÇA

Hermansky-Pudlak syndrome 7

A form of Hermansky-Pudlak syndrome, a genetically heterogeneous autosomal recessive disorder characterized by oculocutaneous albinism, bleeding due to platelet storage pool deficiency, and lysosomal storage defects. This syndrome results from defects of diverse cytoplasmic organelles including melanosomes, platelet dense granules and lysosomes. Ceroid storage in the lungs is associated with pulmonary fibrosis, a common cause of premature death in individuals with HPS.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Nucleus accumbens basal ganglia
37.2 TPM
Artéria tibial
29.7 TPM
Aorta
25.4 TPM
Cólon sigmoide
24.0 TPM
Brain Frontal Cortex BA9
21.5 TPM
OUTRAS DOENÇAS (1)
Hermansky-Pudlak syndrome 7
HGNC:17328UniProt:Q96EV8

Medicamentos e terapias

SORAFENIBPhase 2

Mecanismo: Vascular endothelial growth factor receptor inhibitor

BOSENTANPhase 2

Mecanismo: Endothelin receptor, ET-A/ET-B antagonist

LETROZOLEPhase 2

Mecanismo: Cytochrome P450 19A1 inhibitor

PENTOXIFYLLINEPhase 1

Mecanismo: 3',5'-cyclic phosphodiesterase inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

912 variantes patogênicas registradas no ClinVar.

🧬 BLOC1S3: GRCh38/hg38 19q13.31-13.32(chr19:44626066-46268105)x3 ()
🧬 BLOC1S3: NM_001382422.1(EXOC3L2):c.1999-138A>C ()
🧬 BLOC1S3: NM_212550.5(BLOC1S3):c.87dup (p.Ser30fs) ()
🧬 BLOC1S3: NM_212550.5(BLOC1S3):c.101C>A (p.Ser34Ter) ()
🧬 BLOC1S3: NM_212550.5(BLOC1S3):c.100_101inv (p.Ser34Glu) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 23
1Fase 11
Medicamentos catalogadosEnsaios clínicos· 4 medicamentos · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença de organelas lisossoma-relacionado

Centros de Referência SUS

21 centros habilitados pelo SUS para Doença de organelas lisossoma-relacionado

Centros para Doença de organelas lisossoma-relacionado

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

NUPAD / Faculdade de Medicina UFMG

Av. Prof. Alfredo Balena, 189 - 5 andar - Centro, Belo Horizonte - MG, 30130-100 · CNES 2183226

Serviço de Referência

Rota
Erros Inatos do Metabolismo

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da Universidade Federal de Pernambuco

Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901 · CNES 2561492

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Onofre Lopes (HUOL)

Av. Nilo Peçanha, 620 - Petrópolis, Natal - RN, 59012-300 · CNES 2408570

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto da Criança e do Adolescente (ICr-HCFMUSP)

Av. Dr. Enéas Carvalho de Aguiar, 647 - Cerqueira César, São Paulo - SP, 05403-000 · CNES 2081695

Serviço de Referência

Rota
Erros Inatos do Metabolismo

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Divergent pathways of surfactant protein C maturation for disease-associated isoforms.

The Journal of biological chemistry2026 Feb 05

Surfactant protein C (SP-C), a hydrophobic protein exclusively synthesized and secreted by alveolar type II (AT2) cells, is important for reducing alveolar surface tension in the distal lung. Chronic interstitial pulmonary diseases have been associated with SFTPC mutations. However, a detailed understanding of SP-C maturation in the secretory pathway and disruptions caused by mutations has remained incomplete. The goal of this study was to comprehensively ascertain differences in trafficking and posttranslational processing between WT and disease-associated SP-C mutants using doxycycline-inducible mouse lung epithelial cell lines expressing either WT SP-C or the common clinical variant SP-CI73T, validated using primary AT2 cells isolated from a murine SP-CI73T pulmonary fibrosis model and induced pluripotent stem cell-derived human AT2 cells expressing the same mutant. In all three models SP-CWT was highly concentrated in acidic lysosomal-related organelles while SP-CI73T accumulated on the plasma membrane, which was corroborated by inhibition of clathrin-mediated endocytosis, surface biotinylation, immunogold electron microscopy, immunofluorescent staining, and proteinase K protection assays supporting divergence of SP-CI73T trafficking from SP-CWT. The exclusion of SP-CI73T from normal routing occurred early in the biosynthetic pathway as brefeldin A blocked processing of both SP-C proproteins, while a 20 ˚C temperature shift caused selective accumulation of a processed proSP-CWT intermediate, suggesting initial C-terminal cleavage of proSP-CWT occurs in late-Golgi/trans-Golgi network. This cleavage event was sensitive to DC1, an inhibitor of furin-related subtilisin-like proprotein convertase (PPC) family members. Site-directed mutagenesis of canonical residues K160/R167 within a predicted PPC recognition site in the proSP-C COOH domain blocked its processing. Expression constructs encoding inhibitory pre-proprotein peptide fragments of furin and PC7 each inhibited cleavage of proSP-CWT in mouse lung epithelial-12 cells. Collectively, our data demonstrate that trafficking pathways for maturation of WT and mutant I73T SP-C diverge prior to the trans-Golgi network, where initial cleavage of the COOH-terminal SP-C propeptide occurs via a furin-like proprotein convertase.

#2

Lysosomal Network Defects in Early-Onset Parkinson's Disease Patients Carrying Rare Variants in Lysosomal Hydrolytic Enzyme Genes.

International journal of molecular sciences2025 Sep 27

Despite significant advances in understanding the genetics of Parkinson's disease (PD) and Parkinsonism, the diagnostic yield remains low. Pathogenic variants of GBA1, which encodes the lysosomal enzyme β-glucocerebrosidase and causes recessive Gaucher dis-ease, are recognized as the most important genetic risk factor for PD in heterozygous carriers. This study focuses on the functional genomics of rare genetic variations in other lysosomal hydrolytic enzymes genes in patient-derived fibroblasts. We examined 49 early-onset PD patients using whole exome sequencing and in silico panel analysis based on a curated PD gene list. Two patients were found to carry the p.Asp313Tyr variant in the X-linked GLA gene (encoding GALA, typically associated with Fabry disease), and one patient carried the p.Arg419Gln variant in GLB1 (encoding β-Gal, linked to the recessive GM1 gangliosidosis and mucopolysaccharidosis type IVB). The in silico study of both variants supports a potentially damaging impact on the encoded protein function and structural destabilization. Additional candidate variants were found related to lysosomes, Golgi apparatus and neurodegeneration, suggesting a multifactorial contribution to the disease. However, none of these variants met diagnostic standards. Functional assays showed a significant decrease in GALA expression and partial retention of the enzyme in the trans-Golgi network in fibroblasts with GLA:p.Asp313Tyr, while altered Golgi morphology was observed in fibroblasts with GLB1:p.Arg419Gln. Moreover, all patients exhibited abnormalities in lysosomal morphology, altered lysosomal pH, and impaired autophagic flux. Our findings suggest that rare, heterozygous variants in lysosomal-related genes, even when individually insufficient for monogenic disease, can converge to impair lysosomal homeostasis and autophagic flux in EOPD. The underlying genetic and cellular heterogeneity among patients emphasizes the importance of combining genetic and functional approaches to better understand the mechanisms behind the EOPD, which could enhance both diagnosis and future treatments.

#3

The Golgi complex governs natural killer cell lytic granule positioning to promote directionality in cytotoxicity.

Cell reports2025 Jan 28

Cytotoxic immune cells mediate precise attacks against diseased cells to maintain organismal health. Their operational unit of killing and host defense is lytic granules (LGs), which are specialized lysosomal-related organelles. Precision in cytotoxicity is achieved by converging the many LGs to the microtubule-organizing center (MTOC) and polarizing these to the diseased cell for secretion. We identify unappreciated intimate relationships between the Golgi, MTOC, and LGs after cytotoxic cell activation, as well as the trans-Golgin protein GCC2 on the LG surface. GCC2 serves to tether LGs to the Golgi following convergence, and both GCC2 and the Golgi are required for the persistence of convergence. GCC2 allows LGs to utilize the Golgi as a docking station preventing LG dispersion and innocent bystander killing in complex three-dimensional environments. We also identify GCC2 variants causing human natural killer cell deficiency, further emphasizing the importance of LG convergence and Golgi linkage in precision targeting for human immunity.

#4

Dihydromyricetin restores lysosomal function in Schwann cells to alleviate bortezomib-induced peripheral neuropathy via ERK/TFEB signaling.

Archives of toxicology2025 Jun

Bortezomib (BTZ) serves as a first-line drug for multiple myeloma (MM) treatment by reversibly inhibiting of the proteasomes. However, BTZ-induced peripheral neuropathy (BIPN) remains a significant toxicity concern, with its molecular mechanisms not fully elucidated, resulting in limited therapeutic options. Dihydromyricetin (DHM) has been shown to alleviate neuropathic pain, but its potential effect on BIPN has not been investigated. We found that oral administration of DHM (40 mg/kg/day, 200 mg/kg/day) for 2 weeks significantly improved mechanical allodynia, sciatic nerve conduction, and demyelination in a BIPN mouse model (BTZ 1.0 mg/kg, i.v.). BTZ (50 nmol/L) impaired lysosomal function and blocked autophagy flux in both primary cultured rat Schwann cells and RSC96 Schwann cells; these effects were reversed by DHM treatment (3 μmol/L, 10 μmol/L). Mechanistically, DHM facilitated the nuclear translocation of TFEB, a master regulator of lysosomal-related genes, and the protective effects of DHM on Schwann cells were abolished by Tfeb shRNA. Furthermore, BTZ treatment activated ERK signaling, leading to TFEB phosphorylation and impaired nuclear translocation. DHM treatment prevented the BTZ-induced ERK activation, and the protective effects of DHM were compromised by the ERK activator TBHQ. Importantly, DHM did not diminish the efficacy of BTZ against RPMI 8226 myeloma cells. This study demonstrates that DHM mitigates BTZ-induced toxicity on Schwann cells by restoring lysosome-autophagy activity through the ERK-TFEB pathway, highlighting DHM as a promising candidate for improving the adverse reaction of BTZ in the peripheral nervous system.

#5

Lysosome-related proteins may have changes in the urinary exosomes of patients with acute gout attack.

European journal of medical research2025 Jan 21

The autophagy-lysosome is intricately linked to the development of gout. At present, the diagnosis and monitoring of gout are mainly invasive tests, which cannot predict the occurrence of gout in the acute phase, and bring new pain to patients. This study focuses on the changes of lysosome-related proteins in urinary exosomes of patients with acute gout attack to explore the potential noninvasive biomarkers clinical application value. Urine samples were collected from the subject and exosomes were extracted. To explore the differentially expressed proteins in urinary exosomes among acute gout patients (AD group), intermittent gout patients (ID group) and normal controls (NC group) by DIA mass spectrometry. Urinary exosomal lysosome associated proteins were analyzed and receiver operating characteristic (ROC) curves of differentially expressed proteins were drawn to evaluate their clinical value in monitoring acute gout attack. A total of 1896 proteins were detected between AD group and ID group, of which 121 proteins were differentially expressed (FC > 1.5 and p < 0.05). There were three lysosomal-related proteins differentially expressed in urinary exosomes between AD group and ID group. Compared with the ID group, the expression of Cathepsin Z (CTSZ) and AP-1 complex subunit beta-1 (AP1B1) was increased, while the expression of Lysosome-associated membrane glycoprotein 2 (LAMP2) was decreased in AD group. The ROC analysis showed that CTSZ, AP1B1 and LAMP2 had a strong ability to predict acute gout attack, with AUC of 0.826, 0.847 and 0.882, respectively. There are many specific protein changes in the urinary exosomes of patients with acute gout attack. The urinary exosomes of patients with acute gout attack may exhibit alterations in lysosome-related proteins, particularly CTSZ, AP1B1, and LAMP2, which may become potential biomarkers for monitoring acute gout attack.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 31

2026

Divergent pathways of surfactant protein C maturation for disease-associated isoforms.

The Journal of biological chemistry
2025

Lysosomal Network Defects in Early-Onset Parkinson's Disease Patients Carrying Rare Variants in Lysosomal Hydrolytic Enzyme Genes.

International journal of molecular sciences
2025

Dihydromyricetin restores lysosomal function in Schwann cells to alleviate bortezomib-induced peripheral neuropathy via ERK/TFEB signaling.

Archives of toxicology
2025

Lysosome-related proteins may have changes in the urinary exosomes of patients with acute gout attack.

European journal of medical research
2025

The Golgi complex governs natural killer cell lytic granule positioning to promote directionality in cytotoxicity.

Cell reports
2024

Plekhg5 controls the unconventional secretion of Sod1 by presynaptic secretory autophagy.

Nature communications
2024

AP3B1 Has Type I Interferon-Independent Antiviral Function against SARS-CoV-2.

Viruses
2024

Integrative analysis reveals key lysosomal genes as potential therapeutic targets in Alzheimer's disease.

Metabolic brain disease
2024

Research Progress on the Mechanism of Lysosome in Myocardial Ischemia-Reperfusion Injury Based on Autophagy.

Reviews in cardiovascular medicine
2024

Sequestosome-1 (SQSTM1/p62) as a target in dopamine catabolite-mediated cellular dyshomeostasis.

Cell death &amp; disease
2022

Lysosomal alterations and decreased electrophysiological activity in CLN3 disease patient-derived cortical neurons.

Disease models &amp; mechanisms
2022

[Pulmonary phenotypes of inborn errors of metabolism].

Revue des maladies respiratoires
2022

MEK1/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal function in a model of Alzheimer's Disease.

Molecular psychiatry
2022

Suppression of lysosomal-associated protein transmembrane 5 ameliorates cardiac function and inflammatory response by inhibiting the nuclear factor-kappa B (NF-κB) pathway after myocardial infarction in mice.

Experimental animals
2022

Celastrol, a TFEB (transcription factor EB) agonist, is a promising drug candidate for Alzheimer disease.

Autophagy
2021

Rare Variants Analysis of Lysosomal Related Genes in Early-Onset and Familial Parkinson's Disease in a Chinese Cohort.

Journal of Parkinson's disease
2020

Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease.

International review of neurobiology
2020

Autophagy and Lysosome Storage Disorders.

Advances in experimental medicine and biology
2020

Sex-dependent calcium hyperactivity due to lysosomal-related dysfunction in astrocytes from APOE4 versus APOE3 gene targeted replacement mice.

Molecular neurodegeneration
2020

The 5,7-Dimethoxyflavone Suppresses Sarcopenia by Regulating Protein Turnover and Mitochondria Biogenesis-Related Pathways.

Nutrients
2020

The Mutation of the Ap3b1 Gene Causes Uterine Hypoplasia in Pearl Mice.

Reproductive sciences (Thousand Oaks, Calif.)
2019

Autophagic- and Lysosomal-Related Biomarkers for Parkinson's Disease: Lights and Shadows.

Cells
2018

Harnessing Lysosomal pH through PLGA Nanoemulsion as a Treatment of Lysosomal-Related Neurodegenerative Diseases.

Bioconjugate chemistry
2018

The P2Y12 Receptor Antagonist Ticagrelor Reduces Lysosomal pH and Autofluorescence in Retinal Pigmented Epithelial Cells From the ABCA4-/- Mouse Model of Retinal Degeneration.

Frontiers in pharmacology
2018

The phospholipase A2 activity of peroxiredoxin 6.

Journal of lipid research
2017

Sequence-Based Mapping and Genome Editing Reveal Mutations in Stickleback Hps5 Cause Oculocutaneous Albinism and the casper Phenotype.

G3 (Bethesda, Md.)
2017

Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects.

CNS neuroscience &amp; therapeutics
2017

Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5.

PloS one
2016

Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.

Movement disorders : official journal of the Movement Disorder Society
2016

Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases.

Autophagy
2016

The Role of Oxidized Cholesterol in Diabetes-Induced Lysosomal Dysfunction in the Brain.

Molecular neurobiology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença de organelas lisossoma-relacionado.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença de organelas lisossoma-relacionado

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Divergent pathways of surfactant protein C maturation for disease-associated isoforms.
    The Journal of biological chemistry· 2026· PMID 41654130mais citado
  2. Lysosomal Network Defects in Early-Onset Parkinson's Disease Patients Carrying Rare Variants in Lysosomal Hydrolytic Enzyme Genes.
    International journal of molecular sciences· 2025· PMID 41096722mais citado
  3. The Golgi complex governs natural killer cell lytic granule positioning to promote directionality in cytotoxicity.
    Cell reports· 2025· PMID 39813120mais citado
  4. Dihydromyricetin restores lysosomal function in Schwann cells to alleviate bortezomib-induced peripheral neuropathy via ERK/TFEB signaling.
    Archives of toxicology· 2025· PMID 40188411mais citado
  5. Lysosome-related proteins may have changes in the urinary exosomes of patients with acute gout attack.
    European journal of medical research· 2025· PMID 39838438mais citado
  6. Plekhg5 controls the unconventional secretion of Sod1 by presynaptic secretory autophagy.
    Nat Commun· 2024· PMID 39366938recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:309340(Orphanet)
  2. MONDO:0017739(MONDO)
  3. GARD:21334(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q55787315(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença de organelas lisossoma-relacionado
Compêndio · Raras BR

Doença de organelas lisossoma-relacionado

ORPHA:309340 · MONDO:0017739
Medicamentos
4 registrados
MedGen
UMLS
C5681043
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades